Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (2): 320-322    DOI: 10.31083/j.ejgo.2020.02.4968
Case Report Previous articles |
Malignant mixed mesonephric tumor arising in mesonephric carcinoma: a case report with complete remission after concurrent chemoradiation therapy
Sang Wook Yi1, *()
1 Department of Obstetrics and Gynecology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Gangwon, Korea
Download:  PDF(2204KB)  ( 255 ) Full text   ( 8 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose of Investigation: Malignant mixed mesonephric tumors very rarely arise in mesonephric carcinoma of the uterine cervix. These tumors tend to progress aggressively and belong to the histological group of mixed tumors with both epithelial and mesenchymal components. At diagnosis, most patients present with vaginal bleeding and a palpable mass in the cervix. Because this neoplasm is rare, there is no standard management for these patients, and they should be cared for on a case-by-case basis. Materials and Methods: The author treated a 74-year-old patient with a malignant mixed mesonephric tumor arising in the mesonephric carcinoma. The case report and a literature review are presented here. Results: Because the patient was elderly and had complicating medical problems, the authors could not perform surgical treatment and instead attempted concurrent chemoradiation (CCRT), which contrary to the authors' expectations, resulted in complete remission. Conclusion: For patients with advanced-stage tumors and medically complicating issues, CCRT may represent an alternative therapeutic strategy.
Key words:  Malignant mixed mesonephric tumor arising in mesonephric carcinoma      Concurrent chemoradiation      Complete remission      Cervix      Uterus     
Published:  15 April 2020     
*Corresponding Author(s):  SANG WOOK YI     E-mail:  buzzmi@chol.com

Cite this article: 

Sang Wook Yi. Malignant mixed mesonephric tumor arising in mesonephric carcinoma: a case report with complete remission after concurrent chemoradiation therapy. European Journal of Gynaecological Oncology, 2020, 41(2): 320-322.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.02.4968     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I2/320

[1] Špela Smrkolj, Snježana Frković Grazio, Renata Košir Pogačnik. Endocervical adenocarcinoma in situ with ovarian metastasis: a case report[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 802-805.
[2] Joseph J. Noh, Sir-Yeon Hong, Byeong-gie Kim. Malignant perivascular epithelioid cell tumor (PEComa) of uterus: A case report with literature review[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 495-499.
[3] M. Szarszewska, J. Markowska, A. Czekała, P. Kurzawa. Coexistence of endocervical cancer and Brenner tumor of the ovary. Diagnostic difficulties[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 299-302.
[4] J.-H. Kim, D.-Y. Kim. Imiquimod as an alternative option for young women with high-grade cervical intraepithelial neoplasia[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 943-947.
[5] N. Okabe, M. Fujiwara, M. Mochizuki, K. Ohtsuka, Y. Nishigaya, Y. Kobayashi, H. Kamma. CD34-positive uterine lipoleiomyoma in a postmenopausal woman with chronic glomerulonephritis[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1060-1063.
[6] N. Kosaka, K. Hasegawa, K. Kiuchi, S. Ochiai, E. Motegi, I. Fukasawa. Two cases of recurrent small-cell carcinoma of the uterine cervix treated with amrubicin as salvage chemotherapy[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1100-1103.
[7] H. Oikiri, M. Futagami, J. Watanabe, Y. Yokoyama. Adenocarcinoma of the cervix: its prognosis and difficult pathological diagnosis[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 728-733.
[8] A. Mladěnka, P. Mladěnka, O. Simetka, J. Klát. Intra-operative and postoperative complications depend on operating approach and body mass index in patients with malignant uterus body neoplasm[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 593-598.
[9] Aiping Fan, Chen Wang, Liqin Zhang, Ye Yan, Yingmei Wang, Cha Han, Fengxia Xue. The effect of different cervical transformation zone types on the colposcopic diagnosis of cervical intraepithelial neoplasia[J]. European Journal of Gynaecological Oncology, 2019, 40(2): 290-294.
[10] S. Koyama, S. Fujiwara, M. Yagi, K. Kuritani, M. Watanabe, Y. Shiki. A case of uterine incarceration caused by carcinosarcoma accompanied with pyometra[J]. European Journal of Gynaecological Oncology, 2019, 40(2): 328-330.
[11] Lu-lu Fu, Lian-wen Zheng, Chun-hui Gu. Squamous cell carcinoma of one cervix invading the cavity in a uterus didelphys[J]. European Journal of Gynaecological Oncology, 2019, 40(2): 331-333.
[12] Chao Han, Weimin Kong, Jing Jin, Dan Song, Tingting Liu. Small cell neuroendocrine carcinoma of the cervix complicated with mental abnormality and refractory hyponatremia: a case report[J]. European Journal of Gynaecological Oncology, 2019, 40(1): 160-162.
[13] Z. Protrka, A. Dimitrijevic, N. Jovic, T. Kastratovic, J. Djuric, J. Nedovic, S. Zivanovic, A. Vujic, S.M. Drakulic, N. Djonovic, P. Arsenijevic. Expression analysis of the Beclin-1 in premalignant and malignant tissues of the uterine cervix[J]. European Journal of Gynaecological Oncology, 2018, 39(6): 915-920.
[14] H. Ishibashi, M. Takano, M. Miyamoto, T. Aoyama, T. Yoshikawa, K. Furuya. Prolonged stable disease using pazopanib in recurrent and refractory uterine leiomyosarcoma: a proposal of “pazopanib beyond progression”[J]. European Journal of Gynaecological Oncology, 2018, 39(5): 821-824.
[15] F. Lai-Tiong. Metastatic squamous cell carcinoma of the cervix: complete response under maintenance strategy with bevacizumab[J]. European Journal of Gynaecological Oncology, 2018, 39(5): 828-829.
No Suggested Reading articles found!